Biogen Idec
Article Abstract:
The price appreciation potential of the shares of Biogen Idec for the years 2010-2012 is discussed. The San Diego, California-based company offers products for the long-term management of cancers, autoimmune, and inflammatory diseases.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Pharmaceutical preparations, Pharmaceutical industry, Biogen Idec
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Human Genome Sci
Article Abstract:
The price appreciation potential of Human Genome Sciences, Inc. for the years 2010-2012 is discussed. The Rockville, Maryland-based company develops gene-based pharmaceutical products.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Human Genome Sciences Inc., HGSI
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Biotechnology industry, Biotechnology industries, Stocks, Securities, Stock prices, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.